Evidence map›Paper›PMID 33876937›Full record

ArticleLangmuir : the ACS journal of surfaces and colloids2021

Nuclease Hydrolysis Does Not Drive the Rapid Signaling Decay of DNA Aptamer-Based Electrochemical Sensors in Biological Fluids.

Alexander Shaver, Nandini Kundu, Brian E Young, Philip A Vieira, Jonathan T Sczepanski, Netzahualcóyotl Arroyo-Currás

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Langmuir : the ACS journal of surfaces and colloids, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Codeposition Enhances the Performance of Electrochemical Aptamer-Based Sensors.Langmuir : the ACS journal of surfaces and colloids · 2024
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Alexander ShaverDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21202, United States.ORCID 0000-0002-5478-5291
Nandini KunduDepartment of Chemistry, Texas A&M University, College Station, Texas 77842, United States.
Brian E YoungDepartment of Chemistry, Texas A&M University, College Station, Texas 77842, United States.
Philip A VieiraDepartment of Psychology, California State University Dominguez Hills, Carson, California 90747, United States.ORCID 0000-0003-0792-2836
Jonathan T SczepanskiDepartment of Chemistry, Texas A&M University, College Station, Texas 77842, United States.ORCID 0000-0002-9275-2597
Netzahualcóyotl Arroyo-CurrásDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21202, United States.ORCID 0000-0002-2740-6276
Texas A&M University · USJohns Hopkins University · USCalifornia State University, Dominguez Hills · US

Funding

Mirror Image Aptamers: Next Generation RNA-Binding Reagents for Basic Research and Therapeutic ApplicationsR35GM124974 · NIGMS · TEXAS A&M UNIVERSITY · PI Jonathan Thomas Sczepanski · 2017 to 2026
$3.0M
High precision pharmacokinetic measurements in brain using a novel aptamer-based biosensorSC2GM127268 · NIGMS · CALIFORNIA STATE UNIV-DOMINGUEZ HILLS · PI VIEIRA, PHILIP ANDREW · 2019 to 2021
$422k
NIGMS NIH HHS R35 GM124974NIGMS NIH HHS SC2 GM127268
6 · The paper itself

Abstract

Electrochemical aptamer-based (E-AB) sensors are a technology capable of real-time monitoring of drug concentrations directly in the body. These sensors achieve their selectivity from surface-attached aptamers, which alter their conformation upon target binding, thereby causing a change in electron transfer kinetics between aptamer-bound redox reporters and the electrode surface. Because, in theory, aptamers can be selected for nearly any target of interest, E-AB sensors have far-reaching potential for diagnostic and biomedical applications. However, a remaining critical weakness in the platform lies in the time-dependent, spontaneous degradation of the bioelectronic interface. This progressive degradation-seen in part as a continuous drop in faradaic current from aptamer-attached redox reporters-limits the in vivo operational life of E-AB sensors to less than 12 h, prohibiting their long-term application for continuous molecular monitoring in humans. In this work, we study the effects of nuclease action on the signaling lifetime of E-AB sensors, to determine whether the progressive signal loss is caused by hydrolysis of DNA aptamers and thus the loss of signaling moieties from the sensor surface. We continuously interrogate sensors deployed in several undiluted biological fluids at 37 °C and inject nuclease to reach physiologically relevant concentrations. By employing both naturally occurring d-DNA and the nuclease-resistant enantiomer l-DNA, we determine that within the current lifespan of state-of-the-art E-AB sensors, nuclease hydrolysis is not the dominant cause of sensor signal loss under the conditions we tested. Instead, signal loss is driven primarily by the loss of monolayer elements-both blocking alkanethiol and aptamer monolayers-from the electrode surface. While use of l-DNA aptamers may extend the E-AB operational life in the long term, the critical issue of passive monolayer loss must be addressed before those effects can be seen.

Indexed as

Aptamers, NucleotideBiosensing TechniquesElectrochemical TechniquesElectrodesHumansHydrolysisAptamers, Nucleotide

Identifiers

PMID33876937
PMCPMC8176561
OpenAlexW3154131715

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.